Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schroeter

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
BMC Neuroscience|June 26, 2024
The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic strokeDaniel Navin Olschewski, Nilufar Nazarzadeh, Felix Lange, et al.
Frontiers in Cellular Neuroscience|November 12, 2019
Transcranial Current Stimulation Alters the Expression of Immune-Mediating GenesMonika Rabenstein, Marcus Unverricht-Yeboah, Meike Hedwig Keuters, et al.
Frontiers in Cellular Neuroscience|November 30, 2020
Substrate Elasticity Exerts Functional Effects on Primary MicrogliaStefan J Blaschke, Seda Demir, Anna König, et al.
Frontiers in Pharmacology|November 21, 2022
Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy <i>via</i> modulating their neuroinflammatory and neuroregenerative propertiesInes Klein, Janne Boenert, Felix Lange, et al.
Neurology|July 6, 2026
Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis RegistryHannah Preßler, Frauke Stascheit, Annette Aigner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment OutcomeRafael Klimas, Felix Kohle, Lea Horstkemper, et al.
Faraday Discussions|December 23, 2025
Strategies for compatibilisation of extracted lignin properties with commercial applications: general discussionAgnieszka Brandt-Talbot, Veronica Calado, Isaac Castellan, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
Journal of Neurology|September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisFrauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
BMC Neuroscience|June 26, 2024
The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic strokeDaniel Navin Olschewski, Nilufar Nazarzadeh, Felix Lange, et al.
Frontiers in Cellular Neuroscience|November 12, 2019
Transcranial Current Stimulation Alters the Expression of Immune-Mediating GenesMonika Rabenstein, Marcus Unverricht-Yeboah, Meike Hedwig Keuters, et al.
Frontiers in Cellular Neuroscience|November 30, 2020
Substrate Elasticity Exerts Functional Effects on Primary MicrogliaStefan J Blaschke, Seda Demir, Anna König, et al.
Frontiers in Pharmacology|November 21, 2022
Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy <i>via</i> modulating their neuroinflammatory and neuroregenerative propertiesInes Klein, Janne Boenert, Felix Lange, et al.
Neurology|July 6, 2026
Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis RegistryHannah Preßler, Frauke Stascheit, Annette Aigner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment OutcomeRafael Klimas, Felix Kohle, Lea Horstkemper, et al.
Faraday Discussions|December 23, 2025
Strategies for compatibilisation of extracted lignin properties with commercial applications: general discussionAgnieszka Brandt-Talbot, Veronica Calado, Isaac Castellan, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
Journal of Neurology|September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisFrauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
Pageof 13